Adjuvant radiation therapy for high-risk nodal metastases from cutaneous melanoma (Q37430842)

20 August 2017

1 reference

title

Adjuvant radiation therapy for high-risk nodal metastases from cutaneous melanoma (English)

1 reference

adaptive radiation therapy

20 August 2017

main subject

0 references

author name string

B Ashleigh Guadagnolo

series ordinal

1

1 reference

20 August 2017

Gunar K Zagars

series ordinal

2

1 reference

20 August 2017

publication date

1 April 2009

1 reference

Lancet Oncology Commission

20 August 2017

published in

1 reference

20 August 2017

volume

10

1 reference

20 August 2017

issue

4

1 reference

20 August 2017

page(s)

409-416

1 reference

Global cancer statistics, 2002

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

The role of sentinel lymph node biopsy in the management of melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

Factors that predict the presence of sentinel lymph node metastasis in patients with melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

Adjuvant radiotherapy for cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

Radiation therapy as primary and adjuvant treatment for local and regional melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

Controversies in the management of metastatic melanoma to regional lymphatic basins

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

Is adjuvant radiotherapy necessary after positive lymph node dissection in head and neck melanomas?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

Adjuvant radiation after lymph node dissection for melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

Should adjuvant radiotherapy be recommended following resection of regional lymph node metastases of malignant melanomas?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

Loco-regional nodal relapse in melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

Superficial inguinal and radical ilioinguinal lymph node dissection in patients with palpable melanoma metastases to the groin--an analysis of survival and local recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

Morbidity, mortality and local recurrence following regional node dissection for melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

Radiation therapy for nodal disease in malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

Nodal radiation therapy for metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

Prevention of local recurrence after surgical debulking of nodal and subcutaneous melanoma deposits by hypofractionated radiation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

Combined-modality therapy for patients with regional nodal metastases from melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

A prospective phase II study of adjuvant postoperative radiation therapy following nodal surgery in malignant melanoma-Trans Tasman Radiation Oncology Group (TROG) Study 96.06.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

Adjuvant radiation therapy for regional nodal metastases from malignant melanoma. A randomized, prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

Experience with 998 cutaneous melanomas of the head and neck over 30 years

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

Risk factors for nodal recurrence after lymphadenectomy for melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

Adjuvant radiotherapy following neck dissection and parotidectomy for metastatic malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

Adjuvant postoperative radiotherapy to the cervical lymph nodes in cutaneous melanoma: is there any benefit for high-risk patients?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

Melanoma metastatic to cervical lymph nodes: Can radiotherapy replace formal dissection after local excision of nodal disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

Elective radiotherapy provides regional control for patients with cutaneous melanoma of the head and neck.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

Adjuvant irradiation for cervical lymph node metastases from melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

Standardized axillary lymphadenectomy improves local control but not survival in patients with palpable lymph node metastases of cutaneous malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

Radiation therapy following nodal surgery for melanoma: an analysis of late toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

Locally advanced melanoma: results of postoperative hypofractionated radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

Lymphedema after complete axillary node dissection for melanoma: assessment using a new, objective definition

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

Recurrence patterns and outcome in 1019 patients undergoing axillary or inguinal lymphadenectomy for melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

A Critical Assessment of Adjuvant Radiotherapy for Inguinal Lymph Node Metastases from Melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

Ilioinguinal lymph node dissection for palpable metastatic melanoma to the groin.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

Groin dissection in malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

Positive iliac and obturator nodes in melanoma: survival and prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

Patient risk factors and surgical morbidity after regional lymphadenectomy in 204 melanoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

Fractionation sensitivity (alpha/beta ratio) of human melanoma xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

Dispelling the myths surrounding radiotherapy for treatment of cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

Some factors of importance in the radiation treatment of malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

The role of radiotherapy in recurrent and metastatic malignant melanoma: a clinical radiobiological study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

Clinical radiobiology of malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

Fraction size in external beam radiation therapy in the treatment of melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

Regional radiotherapy as adjuvant treatment for head and neck malignant melanoma. Preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

Postoperative radiotherapy for cutaneous melanoma of the head and neck region.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970043-9

7 January 2021

10.1016/S1470-2045(09)70043-9

Identifiers

DOI

1 reference

20 August 2017

1 reference